Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regulus Therapeutics Inc (NASDAQ:RGLS)

1.40
Delayed Data
As of Mar 24
 +0.15 / +12.00%
Today’s Change
0.94
Today|||52-Week Range
8.90
-37.78%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash17.8M37.3M17.2M14.9M
 
 
 
 
 
Short Term Investment Cash-22.7M19.5M-21.4M-1.0M
 
 
 
 
 
Cash & Short Term Investments114.0M159.7M115.3M76.1M
 
 
 
 
 
 
ReceivablesReceivables79.0K274.0K10.0M1.7M
 
 
 
 
 
 
InventoriesInventories----0.005.6M
 
 
 
Current AssetsPrepaid Expenses----8.2M--
 
 
Other Current Assets3.1M4.9M759.0K4.2M
 
 
 
 
 
Current Assets117.2M165.0M134.3M87.5M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross7.5M8.7M11.9M19.6M
 
 
 
 
 
Depreciation-3.7M-5.2M-6.5M-7.8M
 
 
 
 
 
Intangible Assets1.1M1.2M1.1M1.0M
 
 
 
 
 
Other Assets2.1M3.0M1.4M1.4M
 
 
 
 
 
Total Assets123.1M171.5M141.1M100.7M
 
 
 
 
 
 
LiabilitiesAccounts Payable1.2M2.2M2.7M5.8M
 
 
 
 
 
Short Term Debt0.0023.4M0.000.00
 
 
Accrued Expenses3.0M4.4M6.3M5.6M
 
 
 
 
 
Other Current Liabilities7.9M7.5M7.5M5.6M
 
 
 
 
 
Other Liabilities10.4M35.2M12.6M13.8M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt11.3M0.000.0019.8M
 
 
 
Other Liabilities1.5M322.0K2.3M144.0K
 
 
 
 
 
Total Liabilities29.6M39.5M17.0M44.6M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity93.5M132.0M124.1M56.1M
 
 
 
 
 
Total Shareholder Equity93.5M132.0M124.1M56.1M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding41.8M48.9M52.7M52.9M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.